Fig. 3
From: TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
Knockdown of TMEFF2 in U87 and NFHDCD cells enhanced GBM cell proliferation. a Bar gragh of the RT-PCR of TMEFF2 mRNA expression in U87MG and NFHDCD cells. Error bars represent the SD of repeats of each cell. b and c EdU assay showing different cell proliferation rates in siTMEFF2- and siNC-treated U87MG and NFHDCD cells. Error bars represent the SD of repeats of each cell. d and e CCK8 assay showing different cell proliferation rates in siTMEFF2- and siNC-treated U87MG and NFHDCD cells, respectively. *P < 0.05, **P < 0.01, and ***P < 0.001